Abreos Biosciences

Abreos is pioneering personalized dosing for #biologics to ensure that the right patients get the right drug at the right dose.

[Abreos Biosciences @AbreosBio]

At Abreos Biosciences, we want the Right Drug for the Right Patient at the Right Amount https://t.co/eCgtTThKcD #MedTechInnovator

[Abreos Biosciences @AbreosBio]

Abreos Biosciences enters research collaboration with the FDA’s Center for Drug Evaluation and Research (CDER) https://t.co/Rqw7lpMwIG

[Abreos Biosciences @AbreosBio]

@KrysMendez88 We are a precision medicine company based in SD and alumni of UCSD. We have developed a commercial product for therapeutic drug monitoring of Tysabri and have other products in our pipeline for people suffering from MS. Let's connect! We'd love to share your story

[Abreos Biosciences @AbreosBio]

Announcing partnership with ResearchDx, a CLIA approved, CAP accredited companion diagnostics organization based in Irvine, CA to help design and develop products using Abreos' patented Veritope technology! https://t.co/PrW80Re3Le

[Abreos Biosciences @AbreosBio]

Thank you to @MSNewsToday for sharing @AbreosBio's exciting launch of our FDA-cleared LDT for the drug monitoring of #Tysabri!!

[Multiple Sclerosis News Today @MSNewsToday]

New Post: Test to Monitor Tysabri Levels in RMS Patients, moNATor by Abreos Biosciences, Now Available in US https://t.co/OL8zzESGod

[Abreos Biosciences @AbreosBio]

See what #MultipleSclerosis doctors are saying about #moNATor: “...recent data regarding #Tysabri dosing interval extension and PML risk reduction is a major advance. The moNATor assay provides another tool to the clinician which may help to optimize patient care” -Dr. John Foley

[Abreos Biosciences @AbreosBio]

So excited to be announcing the launch of our first commercial product! Available TODAY! Order your Tysabri laboratory diagnostic test at https://t.co/vPy8M4OlTk https://t.co/VK6jQPFAks

[Abreos Biosciences @AbreosBio]

If you are a #MultipleSclerosis patient on Tysabri, take the guessing game out of dosing regimen with #moNATor, launching NEXT WEEK! Go to https://t.co/ZIUZaHACvW to pre-order your drug monitoring kit now.

[Abreos Biosciences @AbreosBio]

@pfizer sued @JNJ last September after Inflectra failed to gain much traction in the market, despite the fact that it launched at a discount to the blockbuster brand Remicade. Learn how @AbreosBio tech can give your asset greater value to compete on past #Price for #biosimilars

[Abreos Biosciences @AbreosBio]

The commercial availability of #moNATor is ever so important given recent @BiogenMS announcements showing a significant reduction in #PML risk for patients on extended interval dosing (EID). Follow @AbreosBio for the latest updates on our product launch and #MultipleSclerosis

[Abreos Biosciences @AbreosBio]

We are launching a laboratory developed test for precision dose monitoring of Natalizumab (#Tysabri)! Our novel assay addresses the substantial unmet need for physicians to more effectively monitor biologic drug levels in patients with #MultipleSclerosis #PML #PrecisionMedicine

[Connect @CONNECTinSD]

Are you at #AAN2018? Stop by and visit #SpringboardAccelerator grad @AbreosBio (Booth #1260)! #MadeInSanDiego #Neurology https://t.co/OVMwsjOHx0

[Abreos Biosciences @AbreosBio]

There once was a company in LA
Giving out something sweet during the day
Twas only a few
Come one, come all and view
Booth #1260 today!
@AANMember @TheCravory #AAN2018 #Neurology

[Abreos Biosciences @AbreosBio]

Attending #AAN2018? Come by and visit us at booth #1260! We'll be giving out a sweet surprise to the first visitors... Exhibitor hours start Sunday, April 22nd at 11:30 AM. @AANMember #Neurology

[Abreos Biosciences @AbreosBio]

Attending AAN? Come by and visit us at booth #1260! We'll be giving out a sweet surprise to the first visitors... Exhibitor hours start Sunday, April 22nd at 11:30 AM.

[Biocom @Biocom]

Biocom member @AbreosBio (winner of our 2016 Five in 5 challenge) presents on their mission to become the trusted source for biologic drug monitoring & create value for all healthcare stakeholders by ensuring that patients have the right drug at the right dose #BiocomPartnering

[Biocom @Biocom]

Don’t miss our last round of company presentations from @AmarantusBio, Histogen, @AbreosBio, Denovo Biopharma, MDI Therapeutics, and @rapidnovor. The first session starts in 5 minutes! #BiocomPartnering

[Abreos Biosciences @AbreosBio]

@Immuneadvisors Thank you for the kind note!

[Abreos Biosciences @AbreosBio]

"...when the extended dosing regimens were applied, with risk reduction for PML as high as 94 percent."

[Abreos Biosciences @AbreosBio]

Extending Dosing Intervals Reduces Deadly Side Effect Risk from Popular Multiple Sclerosis Drug #PrecisionMedicine #MultipleSclerosis https://t.co/rsvA57zs1t

[Zen Diagnostics @ZenDiagnostics]

Congratulations to the @AbreosBio team - Zen is so proud to be working with you to enable dose monitoring of biologics for the masses! @PMWCintl #PrecisionMedicine #PMWC18 https://t.co/Pegief86Mt